Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2.
Saved in:
| Title: | Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2. |
|---|---|
| Authors: | Luo N; Department of Anatomy and Histology, School of Medicine, Nankai University, Tianjin, China.; Departments of Medicine, Vanderbilt University Medical Center, Nashville TN, USA., Formisano L; Departments of Medicine, Vanderbilt University Medical Center, Nashville TN, USA., Gonzalez-Ericsson PI; Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville TN, USA., Sanchez V; Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville TN, USA., Dean PT; Departments of Medicine, Vanderbilt University Medical Center, Nashville TN, USA., Opalenik SR; Departments of Medicine, Vanderbilt University Medical Center, Nashville TN, USA., Sanders ME; Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville TN, USA., Cook RS; Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville TN, USA.; Cancer Biology Program, Vanderbilt University Medical Center, Nashville TN, USA.; Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville TN, USA.; Department of Biomedical Engineering, Vanderbilt University Medical Center, Nashville TN., Arteaga CL; Departments of Medicine, Vanderbilt University Medical Center, Nashville TN, USA.; Department of Biomedical Engineering, Vanderbilt University Medical Center, Nashville TN., Johnson DB; Departments of Medicine, Vanderbilt University Medical Center, Nashville TN, USA., Balko JM; Departments of Medicine, Vanderbilt University Medical Center, Nashville TN, USA.; Cancer Biology Program, Vanderbilt University Medical Center, Nashville TN, USA.; Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville TN, USA. |
| Source: | Oncoimmunology [Oncoimmunology] 2018 Mar 06; Vol. 7 (6), pp. e1438106. Date of Electronic Publication: 2018 Mar 06 (Print Publication: 2018). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2162-4011 |
|---|---|
| DOI: | 10.1080/2162402X.2018.1438106 |
